| abstract |
the present invention relates to combination therapies that contain one or more parp inhibitors and one or more angiogenesis inhibitors. furthermore, therapeutic uses of such combined therapies for the treatment of various disorders and conditions are described. combined therapies and their uses can be useful to prevent the growth of tumor cells, prevent tumor metastases, induce an immune response or reinforce an immune response. |